EGFR and lung carcinoma: Figure 1 demonstrate the CONSORT diagram and patients flow in detail. At last, we identified a total of 21,026 lung cancer patients treated with EGFR-TKI during the study period. The detailed demographic information of whole EGFR-TKI users is shown in Table 1.